Sinotherapeutics Statistics

Total Valuation

SHA:688247 has a market cap or net worth of CNY 4.75 billion. The enterprise value is 4.00 billion.

Market Cap	4.75B
Enterprise Value	4.00B

Important Dates

The next estimated earnings date is Wednesday, April 30, 2025.

Earnings Date	Apr 30, 2025
Ex-Dividend Date	Oct 25, 2024

Share Statistics

SHA:688247 has 449.00 million shares outstanding. The number of shares has decreased by -2.52% in one year.

Current Share Class	n/a
Shares Outstanding	449.00M
Shares Change (YoY)	-2.52%
Shares Change (QoQ)	+21.32%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	4.21%
Float	90.96M

Valuation Ratios

The trailing PE ratio is 37.75.

PE Ratio	37.75
Forward PE	n/a
PS Ratio	9.44
PB Ratio	3.84
P/TBV Ratio	3.97
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	31.18
EV / Sales	7.80
EV / EBITDA	24.86
EV / EBIT	27.73
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.00
Debt / EBITDA	0.00
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 10.48% and return on invested capital (ROIC) is 7.36%.

Return on Equity (ROE)	10.48%
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	7.36%
Return on Capital Employed (ROCE)	n/a
Revenue Per Employee	1.97M
Profits Per Employee	493,210
Employee Count	260
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +18.50% in the last 52 weeks. The beta is 0.10, so SHA:688247's price volatility has been lower than the market average.

Beta (5Y)	0.10
52-Week Price Change	+18.50%
50-Day Moving Average	10.33
200-Day Moving Average	9.55
Relative Strength Index (RSI)	45.63
Average Volume (20 Days)	4,545,564

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SHA:688247 had revenue of CNY 512.69 million and earned 128.23 million in profits. Earnings per share was 0.28.

Revenue	512.69M
Gross Profit	512.69M
Operating Income	144.18M
Pretax Income	142.38M
Net Income	128.23M
EBITDA	160.86M
EBIT	144.18M
Earnings Per Share (EPS)	0.28

Full Income Statement

Balance Sheet

The company has 747.64 million in cash and 22,087 in debt, giving a net cash position of 747.61 million or 1.67 per share.

Cash & Cash Equivalents	747.64M
Total Debt	22,087
Net Cash	747.61M
Net Cash Per Share	1.67
Equity (Book Value)	1.24B
Book Value Per Share	2.76
Working Capital	n/a

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of 28.12% and 25.01%.

Gross Margin	100.00%
Operating Margin	28.12%
Pretax Margin	27.77%
Profit Margin	25.01%
EBITDA Margin	31.38%
EBIT Margin	28.12%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.05, which amounts to a dividend yield of 0.48%.

Dividend Per Share	0.05
Dividend Yield	0.48%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	2
Payout Ratio	n/a
Buyback Yield	2.52%
Shareholder Yield	3.00%
Earnings Yield	2.70%
FCF Yield	n/a

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a